Target intelligence / Profile preview

High-mannose N-linked oligosaccharides (High-mannose glycans)

Target
High-mannose glycans
Molecular classification
Carbohydrate, Glycan, Post-translational modification
01

Overview

High-mannose N-linked oligosaccharides are a specific class of carbohydrates characterized by a branched structure of mannose residues attached to a chitobiose core, which is linked to asparagine residues on proteins. In the context of viral pathogens like HIV-1, Influenza, and Coronaviruses, these glycans are prominent features of the envelope glycoproteins, such as gp120 or the Spike protein. They are often referred to as the "glycan shield" because they mask protein epitopes from the host's immune system, facilitating immune evasion by preventing the binding of most neutralizing antibodies. Despite this protective role, the dense clusters of high-mannose glycans create unique molecular patterns that can be exploited for therapeutic intervention. Carbohydrate-binding agents, such as the plant-derived lectin Griffithsin or broadly neutralizing antibodies like PGT121, specifically recognize and bind these glycans to neutralize the virus by preventing its entry into host cells. These targets are particularly valuable because glycosylation sites are often more conserved than the underlying protein sequences across different viral strains.

Other names
Oligomannose-type N-glycansHigh-mannose glycansViral envelope glycansMannose-rich N-glycansGlycan shield
02

Mechanism of action

Binding to terminal mannose residues on viral glycoproteins to sterically block receptor binding sites or prevent conformational changes required for viral-host membrane fusion.

03

Biological functions

Viral entryProtein foldingImmune evasionHost-pathogen interactionProtein stability
04

Disease associations

InfectionHIV/AIDSCOVID-19InfluenzaEbola virus diseaseHepatitis C
05

Safety considerations

Potential cross-reactivity with host glycoproteins containing high-mannose structuresImmunogenicity of non-human lectinsOff-target binding to endogenous mannose-containing receptorsPotential for viral resistance through glycan site mutations
06

Interacting drugs

Griffithsin

7 more in the full profile.

07

Biomarkers

Viral glycan profilingSerum mannose-binding lectin levelsNeutralizing antibody titers

Beyond the preview

Go deeper on High-mannose N-linked oligosaccharides (High-mannose glycans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High-mannose N-linked oligosaccharides (High-mannose glycans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call